Skip to main content

Retail Clinics

  • Spring sports physicals now available at MinuteClinic

    WOONSOCKET, R.I. — MinuteClinic announced that it is offering spring sports physicals at its facilities across the country to make it easier and more affordable for children and teenagers to head to the field and participate in organized sports.

    Beginning March 1 to 31, MinuteClinic will offer the pre-participation physicals, which are required by many states, school systems and athletic leagues. MinuteClinic nurse practitioners and physician assistants will offer the exams seven days a week, including weekday evenings. No appointment is necessary.

  • NSAIDs could pose erectile dysfunction risk among men

    PASADENA, Calif. — Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

    The study, sponsored by Kaiser Permanente and published online in the Journal of Urology, found that men who took nonsteroidal anti-inflammatory drugs, or NSAIDs, three times a day for more than three months were 2.4 times as likely to have erectile dysfunction as men who didn’t take the drugs regularly. The study used data from 80,966 men ages 45 to 69 years in California.

  • FDA targets unapproved cough-cold, allergy drugs with Unapproved Drugs Initiative

    SILVER SPRING, Md. — The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

    The action is part of the agency’s Unapproved Drugs Initiative, which seeks to remove from the market drugs that have not received approval. In many cases, the drugs were marketed before the FDA adopted its current regulatory standards.

  • Max-Wellness, Humana partner on new in-home healthcare solutions service

    WOODMERE, Ohio — Health-and-wellness retailer Max-Wellness on Tuesday announced a series of initiatives that vastly will expand the reach of the upstart company.

    Among them:

  • Report: FDA warns of long-term PPI use

    SILVER SPRING, Md. — The Food and Drug Administration is warning that long-term use of a class of drugs for gastroesophageal reflux disease may decrease levels of magnesium in the body and increase the risk of such side effects as seizures and heart rhythm problems, according to published reports.

    The reports quoted the FDA as saying that in a quarter of cases of proton-pump inhibitors depleting magnesium from the body, use of magnesium supplements did not bring levels back to normal, and use of the drugs had to be stopped.

  • Sugary drinks associated with hypertension, study finds

    DALLAS — A new study published in Hypertension: Journal of the American Heart Association established a link between high blood pressure and the consumption of such beverages as soda and other sugar-sweetened drinks.

  • Cold sore treatment Xerese enters market

    HUDDINGE, Sweden — Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

    The Swedish drug maker launched Xerese (acyclovir and hydrocortisone), a topical combination product designed to treat recurrent herpes simplex labialis.

    Medivir said the U.S. market for cold sore products is $230 million, and it expected the drug to be successful, given Meda’s presence in the U.S. market.

  • Study: Physicians more likely to prescribe Rxs with adherence incentives

    NEW YORK — Physicians are 30% more likely to prescribe a drug that gives patients incentives to remain adherent to it than they are to prescribe a drug without such a program, according to a new survey.

    The survey of 100 doctors, sponsored by HealthPrize Technologies and conducted by pharmaceutical marketing firm HealthcarePanel.org, also found 89% of doctors were comfortable with the idea of rewarding patients for adherence, along with using education.

X
This ad will auto-close in 10 seconds